What is important in dialysis? Efficiency: Blood flow, KoA and Kt/V?

Contributions to Nephrology

Volumn 161, Issue , 2008, Pages 168-177

  Gotch, F ^a,b  

^a RENAL RESEARCH INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UREA;

CIRCULATION; HUMAN; METABOLIC CLEARANCE RATE; METABOLISM; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; REVIEW; TIME; UREA NITROGEN BLOOD LEVEL;

BLOOD CIRCULATION; BLOOD UREA NITROGEN; HUMANS; METABOLIC CLEARANCE RATE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; TIME FACTORS; UREA;

EID: 48049106035     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000130674     Document Type: Conference Paper

References (12)

1. Lowrie EG: History and organization of the National Cooperative Dialysis Study (NCDS). Kidney Int 1983;13(suppl):S1-S221.
2. Eknoyan G, Beck G, Cheung A, et al: Effect of dialysis dose and membrane flux in maintenance dialysis. N Engl J Med 2002;347:2010-2019.
3. Sargent JA: Control of dialysis by a single pool urea model: the National Cooperative Dialysis Study. Kidney Int 1983;13(suppl):S19-S25.
4. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study. Kidney Int 1985;28:526-534.
5. Keshaviah PR: Urea kinetic and middle molecule approaches to assessing the adequacy of hemodialysis and CAPD. Kidney Int Suppl 1993;40:S228-S238.
6. Held P, Port F, Wolf R, Stannard D, Carroll D, Daugirdas J, Bloembergen W, Greer J, Hakim R: The dose of hemodialysis and patient mortality. United States Renal Data System, University of Michigan, Ann Arbor, USA.
7. Greene T, Daugiordas J, Depner T, Allon M, et al, Hemodialysis Study Group: Association of achieve dialysis dose with mortality in the hemodialysis study: an example of 'dose targeting bias'. J Am Soc Nephrol 2005;11:3371-3380.
8. Saran R, Brago-Gresham J, Levin N, Twardowski Z, et al: Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality with treatment time in the DOPPS. Kidney Int 2006;69:1222-1228.
9. Marshall MR, Byrne BG, Kerr PG, McDonald SP: Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients. Kidney Int 2006;69:1229-1236.
10. Twardowski ZL: Short, thrice-weekly hemodialysis is inadequate regardless of small molecule clearance. Int J Artif Organs 2004;27:452-467.
11. Kurella M, Chertow G: Dialysis session length (t) as a determinant of the adequacy of dialysis. Semin Nephrol 2005;2:90-95.
12. Gotch F, Uehlinger D: Mortality rate in US dialysis patients. Dial Transplant 1991;20:255057.